June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Quantitative Trait Analysis of Timolol Response—A Combined Analysis
Author Affiliations & Notes
  • Sayoko Eileen Moroi
    Ophthalmology & Visual Sciences, Univ of Michigan-Kellogg Eye Ctr, Ann Arbor, MI
  • Matthew G J Trese
    Ophthalmology & Visual Sciences, Univ of Michigan-Kellogg Eye Ctr, Ann Arbor, MI
  • David M Reed
    Ophthalmology & Visual Sciences, Univ of Michigan-Kellogg Eye Ctr, Ann Arbor, MI
  • Diana Burnett
    Ophthalmology & Visual Sciences, Univ of Michigan-Kellogg Eye Ctr, Ann Arbor, MI
  • Vikas Gulati
    Department of Ophthalmology and Visual Sciences, University of Nebraska Medical Center, Omaha, NE
  • Arash Kazemi
    Department of Ophthalmology, The Mayo Clinic, Rochester, MN
  • Jay W McLaren
    Department of Ophthalmology, The Mayo Clinic, Rochester, MN
  • Arthur J Sit
    Department of Ophthalmology, The Mayo Clinic, Rochester, MN
  • David C Musch
    Ophthalmology & Visual Sciences, Univ of Michigan-Kellogg Eye Ctr, Ann Arbor, MI
  • Carol B Toris
    Department of Ophthalmology and Visual Sciences, University of Nebraska Medical Center, Omaha, NE
    Department of Ophthalmology and Visual Sciences, Case Western Reserve University, Cleveland, OH
  • Footnotes
    Commercial Relationships Sayoko Moroi, NEI (F); Matthew Trese, None; David Reed, RPB (F); Diana Burnett, None; Vikas Gulati, NEI (F); Arash Kazemi, None; Jay McLaren, None; Arthur Sit, NEI (F); David Musch, NEI (F); Carol Toris, NEI (F)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 5690. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sayoko Eileen Moroi, Matthew G J Trese, David M Reed, Diana Burnett, Vikas Gulati, Arash Kazemi, Jay W McLaren, Arthur J Sit, David C Musch, Carol B Toris; Quantitative Trait Analysis of Timolol Response—A Combined Analysis. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):5690.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To determine the variations in the response of aqueous humor flow rate (flow) and intraocular pressure (IOP) in normal subjects treated with timolol.

Methods: The response of flow and IOP to timolol was studied in 92 normal participants (age 41.8 ± 16.0 years, 41% males). Fifty-three of these were studied in an inpatient setting to determine how their aqueous humor flow rate responded to timolol. Morning flow was assessed by fluorophotometry at baseline (no treatment) and after treatment with timolol 0.5%. Thirty-nine participants, who were part of a prospective, multicenter study, were evaluated for aqueous humor dynamic traits and IOP response to timolol. Outcome measures were the percent change in flow (∆ flow) and the percent change in IOP (∆ IOP). A treatment response, ∆ flow and ∆ IOP, of 15% or greater was considered clinically significant and designated a responder; conversely a response of less than 15% was considered as a “non-responder”. Treatment responses were analyzed by paired t-test.

Results: Flow decreased from 2.6 ± 0.8 µl/min (mean ± SD) to 1.7 ± 0.5 µl/min (p<0.0001) after timolol. ∆ Flow was 15% or more in 73/92 of subjects (79%) after treatment with timolol; the non-responder rate was 21%. IOP decreased from 13.7 ± 3.4 mmHg to 11.4 ± 3.6 mmHg (p<0.05) after timolol. ∆ IOP was 15% or more in 23/39 subjects (59%); the non-responder rate was 41%.

Conclusions: This combined analysis provides evidence of variation in the response of aqueous humor flow and IOP to timolol; flow rate does not respond in approximately 21% of the population and IOP does not respond in approximately 41%.The source of this variation could be other variables of aqueous humor dynamics expressed in the Goldmann equation or unidentified genetic or environmental factors. Additional analyses will determine the concordance between ∆ flow and ∆ IOP in response to timolol, will examine covariates of drug response, and will identify genetic factors that affect drug response.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×